Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy

Japan's Ministry of Health, Labour and Welfare (MHLW) grants MCO-010 Sakigake (Pioneering Regenerative

CPHI & PMEC China 2023 to see surge from pent up international ingredients demand

The largest pharma show in Asia makes its return to Shanghai this June 2026

SHANGHAI, March 2, 2026 /PRNewswire/ -- CPHI " alt="The largest pharma show in Asia makes its

CPHI South East Asia 2025: Your gateway to ASEAN's expanding pharmaceutical landscape

KUALA LUMPUR, Malaysia, May 2, 2025 /PRNewswire/ -- As Southeast Asia's pharmaceutical industry rapidly

Xinhua Silk Road: E. China Jiangsu's Wuxi to strengthen economic, trade and cultural co-op with Japan

HYOSUNG Chairman Hyun-Joon Cho actively works for greater economic cooperation between Korea and Japan

Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan

Lessons from Japan's AMR Response for the Global Community

TOKYO, Feb. 25, 2025 /PRNewswire/ -- World Health Organization (WHO) Regional Office for the Western Pacific

Dobot Opens Japan Subsidiary to Better Serve Japanese Market